FindTrial
Sign In

Clinicopathological characteristics and prognostic factors of primary poorly-differentiated neuroendocrine neoplasms in gallbladder

Clinicopathological characteristics and prognostic factors of primary poorly-differentiated neuroendocrine neoplasms in gallbladder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052349
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary poorly-differentiated neuroendocrine neoplasms in gallbladder

Interventions

Test group:None

Sponsors

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. The primary tumor is located in the gallbladder; 2. Pathologically confirmed diagnosis of gallbladder neuroendocrine tumors (GB-NENs); 3. Clearly record the medical history of each patient, including symptoms, diagnosis, treatment methods and prognosis; 4. Patients who voluntarily signed the informed consent and were able to complete the follow-up plan.

Exclusion criteria

Exclusion criteria: 1. Patients with well-differentiated GB-NENs (GB-NETs and well-differentiated MINENs); 2. Those who have no legal capacity or insight.

Design outcomes

Primary

MeasureTime frame
Overall Survival;—

Secondary

MeasureTime frame
Progression free survival;—

Countries

China

Contacts

Public ContactWang Jian

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University

dr_wangjian@126.com+86 13818965695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026